Can-Fite BioPharma Ltd. SEC filings CANF

Can-Fite BioPharma Ltd. has 865 filings in SEC EDGAR's recent list, going back to Dec 1, 2011. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 26, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Apr 14, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Mar 28, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 30, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 24, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 25, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Mar 27, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) Apr 2, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 29, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 28, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Mar 30, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Mar 31, 2016 Dec 31, 2015
20-F Annual report (foreign issuer) Mar 27, 2015 Dec 31, 2014
20-F Annual report (foreign issuer) Mar 31, 2014 Dec 31, 2013

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CANF (NYSE)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ramat Gan, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1536196

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.